Fox Chase Cancer Center’s Colleen Tetzlaff Recognized With Inaugural Sharon Schwartz Award

PHILADELPHIA (April 16, 2021)—Colleen H. Tetzlaff, MHS, PA-C, advanced practice clinician in the Department of Hematology/Oncology at Fox Chase Cancer Center, has been recognized as the recipient of the first-ever Sharon Schwartz Award, which is presented by the Recognition and Development Model (RDM) Committee at Fox Chase.

The award recognizes one applicant who has performed above and beyond their clinical duties by taking part in activities that greatly contribute to the mission of Fox Chase.

Colleen H. Tetzlaff, advanced practice clinician in the Department of Hematology/Oncology at Fox Chase, receiving the Sharon Schwartz Award
Colleen H. Tetzlaff, advanced practice clinician in the Department of Hematology/Oncology at Fox Chase, receiving the Sharon Schwartz Award

“I am incredibly honored to receive the inaugural RDM Sharon Schwartz Award. It is humbling to be recognized and chosen to receive this award among a group of such accomplished and deserving peers, and also in the memory of our beloved colleague Sharon,” said Tetzlaff.

Sharon Schwartz, MSN, CRNP, was a member of the Fox Chase team who showed extraordinary dedication to her gynecologic oncology, gynecologic survivorship, and clinical genetics practice. Schwartz played a major role in developing services like the Oncofertility Program, which aids patients facing fertility issues along with their cancer diagnosis. Schwartz passed away on January 31, 2020.

“As one of the earlier Fox Chase Nurse Practitioners, she was a leader in bringing together the Advanced Practice Clinicians (APC) community with successful programs such as the APC Committee, Continuing Education Program and, notably, the RDM program, which seeks to recognize and celebrate APC achievements every year,” the RDM Committee stated in their annual report. “She embodied grace and grit which carried over to her professional career, and the RDM Committee is so honored to acknowledge in her name the hard work of her colleagues of whom she was so proud.”

Tetzlaff was selected for this award from dozens of nurse practitioners and physician assistant applicants for her work in helping to start the RDM program, serving as its chair, and continuing to improve it. She also reintroduced the APC Annual Report and was recently elected president of the Association of Physician Assistants in Oncology Board of Directors.

“I had the privilege of working with and becoming friends with Sharon as we served on multiple committees together at Fox Chase over the years. Sharon’s dedication to her patients, Fox Chase, the advanced practice provider community, and her family was unwavering. To receive this award in honor of such a respected and admired colleague, both professionally and personally, is very special,” said Tetzlaff.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427